APAC Heart Failure Market, Market Segmented, by Type (Injection, Capsule, Tablets and Other), by Application (Hospital, Clinic, Household, and Others), and by Treatment (Entresto, Procoralan, ACE Inhibitors, ATR Blockers and Beta Blockers), and by Therapies (Carperitide, Diuretics and Isosorbide Dinitrate) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138342
- Pages: 200
-
Format:
Report Overview
The APAC Heart Failure Market, market size stood at around USD $1.4 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Heart failure, sometimes known as congestiveheart failure, occurs when yourheartmuscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in yourheart(coronary arterydisease) or high blood pressure, gradually leave yourhearttoo weak or stiff to fill and pump efficiently
Market Drivers
Rising prevalence and growing awareness of the disease to drive market growth. Promising pipeline products that target unmet needs for HF. Increasing awareness and diversified healthcare reform to boost market growth
1. APAC Heart Failure Market Overview
A. Market Size
2. APAC Heart Failure Growth Drivers
A. Rising Prevalence and Growing Awareness of the Disease
B. Promising Pipeline Products that Target Unmet Needs for HF
C. Increasing Awareness and Diversified Healthcare Reform
3. APAC Heart Failure Market Segmentation
A. By Type
I. Injection
II. Capsule
III. Tablets
IV. Other
B. By Application
I. Hospital
II. Clinic
III. Household
IV. Others
C. By Treatment
I. Entresto
II. Procoralan
III. ACE Inhibitors
IV. ATR Blockers
V. Beta Blockers
D. By Therapies
I. Carperitide
II. Diuretics
III. Isosorbide Dinitrate
4. Heart Failure Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. AstraZeneca, Company overview, Product & Services, Strategies & Financials
B. Bayer AG, Company overview, Product & Services, Strategies & Financials
C. Novartis AG, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
